Disclosure 0001827672-26-000013-2

SEC FORM 4

$264,683.00

Tarsus Pharmaceuticals, Inc. (TARS)

Sale of 2,900 shares at $91.27 per share.

Reporting Person Azamian Bobak R. · Officer Title President/CEO and Board Chair · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0001827672-26-000013 · filed 2026-09-09 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Tarsus Pharmaceuticals, Inc. (TARS)." Disclosed 2026-09-09. https://desqlong.com/cards/0001827672-26-000013-2 (retrieved 2026-09-26).